30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

3Q13 Revenue: Zimmer

$1,074MM, +7% (Americas $633MM, +9%; EMEA $255MM, +1%; Asia Pacific $186MM, +8%)

Reconstructive $788MM, +6% (Americas $455MM, +8%; EMEA $196MM, flat; Asia Pacific $137MM, +7%)

  • Hips $308MM, +2% (Americas $150MM, +4%; EMEA $97MM, -2%; Asia Pacific $61MM, +5%)
  • Knees $435MM, +7% (Americas $270MM, +9%; EMEA $92MM, +1%; Asia Pacific $73MM, +9%)
  • Extremities $45MM, +15% (Americas $34.9MM, +14%; EMEA $7.8MM, +20%; Asia Pacific $2.8MM, +9%)

Dental $55MM, flat

Trauma $79MM, +8% (Americas $39.7MM, +2%; EMEA $19.4MM, +16%; Asia Pacific $19.4MM, +12%)

Spine $48MM, -3% (Americas $31.4MM, -7%; EMEA $11.3MM, +6%; Asia Pacific $5.3MM, -7%)

Surgical/Other $104MM, +25% (Americas $70.9MM, +36%; EMEA $13.9MM, +14%; Asia Pacific $19.6MM, -7%)

 

  • Pricing -1.5%, consistent with expectations; Hips volume/mix +4.3%, price -2.1%; Knees volume/mix +9.1%, price -1.7%; Extremities volume/mix +17%, price -2%; Trauma volume/mix +8%, price flat; Spine volume/mix -1%, price -2%
  • Hip growth buoyed by U.S. shift toward Continuum acetabular system, Vivacit-E liners, Biolec ceramic heads, global growth in Avenir and Fitmore
  • Knee sales supported by Persona knee (sales growing steadily, with excellent feedback from new and legacy customers—“healthy portion” of acceleration from competitive surgeons) and Gel-One single-injection osteoarthritis treatment (latter sales remain in $5MM to $10MM range)
  • Extremities growing above market performance in all geographies
  • Received 510(k) clearance for Patient Specific Instruments shoulder system
  • Obtained 510(k) clearance for MotionLoc screw for periarticular locking plate system
  • Spine sales led by Trabecular Metal Ardis, TM-S Interbody Fusion, inViZia interior cervical plate
  • Entered into exclusive global distribution agreement with Frontier Medical Devices to market a Zimmer-branded minimally invasive Lateral Locking Cage; “in a good position” to have retractor and neuro monitoring systems to support entry to the lateral market